FDA Approves New Drug for Rheumatoid Arthritis
Mon, 11 Jan 2010 13:09:00 -0600
The U.S. Food and Drug Administration approved Actemra (tocilizumab) on Friday to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis.
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
![Fight Flu with Facts! Visit flu.gov. Call 800-232-4636. Text FLU to 87000.](http://www.cdc.gov/emailupdates/images/h1n1emailcollab.gif)
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420